OTCMKTS:RSLS

ReShape Lifesciences - RSLS News Today

$2.80

-0.13 (-4.44%)

(As of 03/30/2023 12:00 AM ET)

Add

Compare

Today's Range: $2.77
▼
$3.06
50-Day Range: $2.66
▼
$17.04
52-Week Range: $2.49
▼
$77.00

Volume: 40,729 shs
Average Volume: 207,757 shs
Market Capitalization: $1.46 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $2.88

Institutional Ownership

Headlines

SEC Filings

Short Interest

Get ReShape Lifesciences News Delivered to You Automatically

RSLS Media Mentions By Week

RSLS Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

RSLS
News Sentiment
▼
-0.76

0.60
▲
Average
Medical
News Sentiment

RSLS News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

RSLS Articles
This Week
▼
2

0
▲
RSLS Articles
Average Week

Source

Source	Headline
	Reshape Lifesciences Stock (NASDAQ:RSLS), Guidance and Forecast benzinga.com - March 30 at 3:20 PM
	ReShape Lifesciences® To Delay Year Ended December 31, 2022 Earnings Release and Conference Call finance.yahoo.com - March 29 at 1:00 AM
	ReShape Lifesciences Announces Formation of International Scientific Advisory Board finance.yahoo.com - March 23 at 9:05 AM
	ReShape Lifesciences® to Announce Financial Results for the Year Ended December 31, 2022, and Provide Corporate Update finance.yahoo.com - March 22 at 9:01 AM
	ReShape Lifesciences(R) to Present at the Q2 Virtual Investor Summit marketwatch.com - March 17 at 11:28 PM
	ReShape Lifesciences® to Present at the Q2 Virtual Investor Summit finance.yahoo.com - March 15 at 8:39 AM
	ReShape Lifesciences Shares Drop 60% After Public Offering Prices marketwatch.com - February 6 at 11:09 AM
	Why ReShape Lifesciences (RSLS) Shares Are Plummeting msn.com - February 6 at 11:09 AM
	ReShape Lifesciences Announces Pricing of Upsized $10.2 Million Underwritten Public Offering finance.yahoo.com - February 6 at 11:09 AM
	ReShape Lifesciences Announces Pricing of Upsized $10.2 Million Underwritten Public Offering finance.yahoo.com - February 6 at 11:09 AM
	ReShape Lifesciences Stock More Than Doubles to $14.39 marketwatch.com - February 4 at 12:15 AM
	Looking Into Reshape Lifesciences's Recent Short Interest msn.com - January 4 at 2:15 PM
	Reshape Lifesciences Earnings Perspective: Return On Capital Employed msn.com - December 27 at 1:32 PM
	ReShape Lifesciences Announces 1-for-50 Reverse Stock Split Effective as of Commencement of Trading on December 23, 2022 finance.yahoo.com - December 22 at 8:45 AM
	ReShape Lifesciences™ to Announce Financial Results for the Third Quarter Ended September 30, 2022, and Provide Corporate Update finance.yahoo.com - November 8 at 11:47 AM
	ReShape Lifesciences Announces $750,000 Registered Direct Offering finance.yahoo.com - November 8 at 11:47 AM
	ReShape Lifesciences™ Presents Data on Proprietary Diabetes Bloc-Stim Neuromodulation™ Device at ObesityWeek® finance.yahoo.com - November 3 at 10:55 AM
	ReShape Lifesciences™ Announces That the ASMBS and IFSO Have Issued Updated Guidelines on Indications for Metabolic and Bariatric Surgery, Including the Lap-Band® finance.yahoo.com - October 31 at 10:25 AM
	ReShape Lifesciences™ Announces Publication of Data on Proprietary Diabetes Bloc-Stim Neuromodulation™ (DBSN™) System in Peer Reviewed, Frontiers in NeuroScience finance.yahoo.com - October 25 at 10:36 AM
	ReShape Lifesciences™ Announces Release of a Positive Consensus Statement on Lap-Band® Use and Lap-Band® Aftercare Management by the American Society of Metabolic and Bariatric Surgery (ASMBS) finance.yahoo.com - October 20 at 9:28 AM
	ReShape Lifesciences Appoints Seasoned Sales and Marketing Executive, Nick Ansari, as Senior Vice President of Global Commercial Operations finance.yahoo.com - August 23 at 5:14 PM
	ReShape Lifesciences Inc. Reports Q2 Net Loss of $7.8M investing.com - August 16 at 8:18 PM
	ReShape Lifesciences(TM) Receives FDA 510(k) Clearance for the GIBI HD(TM) Calibration Tubes for use in Gastric and Bariatric Procedures marketwatch.com - August 12 at 1:50 AM
	ReShape Lifesciences' GIBI HD Calibration Tubes Scores FDA Approval For Tummy Tuck Procedures finance.yahoo.com - August 10 at 9:20 PM
	ReShape Lifesciences™ to Announce Financial Results for the Second Quarter Ended June 30, 2022 and Provide Corporate Update finance.yahoo.com - August 10 at 9:20 PM
	ReShape Lifesciences Enters into Warrant Exercise Transaction for $2.5 Million in Gross Proceeds finance.yahoo.com - June 17 at 5:12 PM
	Reshape Lifesciences (NASDAQ:RSLS), Analyst Ratings, Price Targets, Predictions benzinga.com - May 30 at 5:34 AM
	ReShape Lifesciences and OpenLoop Sign Agreement to Provide Nationwide Virtual Health Services for Weight Loss and Wellness Through reshapecare™ finance.yahoo.com - May 26 at 12:23 PM
	ReShape Lifesciences Inc.'s (RSLS) CEO Bart Bandy on Q1 2022 Results - Earnings Call Transcript seekingalpha.com - May 23 at 7:16 PM
	ReShape Lifesciences earnings preview: what Wall Street is expecting markets.businessinsider.com - May 22 at 9:49 AM
	ReShape Lifesciences™ Announces Vernon Vincent to be Recognized as the Distinguished Industry Partner at the ASMBS 2022 LEAD Gala and Awards finance.yahoo.com - May 19 at 3:30 PM
	ReShape Lifesciences™ to Announce Financial Results for the First Quarter Ended March 31, 2022 and Provide Corporate Update finance.yahoo.com - May 16 at 10:57 AM
	ReShape Lifesciences to Present at the Q2 Investor Summit finance.yahoo.com - April 26 at 8:45 AM
	Earnings Update: ReShape Lifesciences Inc. (NASDAQ:RSLS) Just Reported And Analysts Are Trimming Their Forecasts finance.yahoo.com - March 31 at 3:53 PM
	ReShape Lifesciences Inc. (RSLS) uk.finance.yahoo.com - March 28 at 11:03 PM
	ReShape Lifesciences GAAP EPS of $5.00, revenue of $13.69M seekingalpha.com - March 28 at 6:03 PM
	ReShape Lifesciences™ Reports Year Ended 2021 Financial and Operating Results and Provides Corporate Update finance.yahoo.com - March 28 at 6:03 PM
	Earnings Preview For Reshape Lifesciences benzinga.com - March 27 at 10:30 PM
	ReShape Lifesciences™ Experiences Continued Momentum of Direct-to-Consumer Marketing Campaign for the Lap-Band® finance.yahoo.com - March 24 at 2:53 PM
	ReShape Lifesciences to Participate in Investor Conferences in March finance.yahoo.com - March 9 at 8:40 AM
	ReShape Lifesciences™ to Participate in the American Society for Metabolic and Bariatric Surgery’s (ASMBS) Leadership Academy and re-UNITED Meeting January 19-22, 2022 in Las Vegas finance.yahoo.com - January 18 at 9:18 AM
	ReShape Lifesciences Strengthens Leadership Team with Appointment of Michael Bordainick as Senior Vice President, Commercial Operations finance.yahoo.com - January 13 at 9:46 AM
	ReShape Lifesciences to Webcast Live at Life Sciences Investor Forum on December 16th finance.yahoo.com - December 9 at 10:44 AM
	ReShape Lifesciences Witnesses Great Success with Direct-to-Consumer Marketing Campaign finance.yahoo.com - November 16 at 12:53 PM
	ReShape Lifesciences Reports Third Quarter and Nine Month 2021 Financial and Operational Results finance.yahoo.com - November 11 at 9:37 AM
	ReShape Lifesciences to Report Third Quarter 2021 Financial and Operational Results on Thursday, November 11, 2021 finance.yahoo.com - November 8 at 10:11 AM
	ReShape Lifesciences to Present at Dawson James 6th Annual Small Cap Growth Conference finance.yahoo.com - October 19 at 10:31 AM
	ReShape Lifesciences to Present at Dawson James 6th Annual Small Cap Growth Conference finance.yahoo.com - October 19 at 10:31 AM
	ReShape Launches National Advertising Campaign for Flagship Product, Lap-Band® finance.yahoo.com - October 12 at 10:09 AM
	ReShape Lifesciences™ Featured in BioTuesdays finance.yahoo.com - September 23 at 9:17 AM

Get ReShape Lifesciences News Delivered to You Automatically

This page (OTCMKTS:RSLS) was last updated on 3/31/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

ReShape Lifesciences - RSLS News Today

RSLS Media Mentions By Week

RSLS Media Sentiment

RSLS News Coverage

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info